Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Abstract Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of primary and secondary cardiovascular diseases (...
Saved in:
Main Authors: | Hayder M. Al‐kuraishy (Author), Ali I. Al‐Gareeb (Author), Athanasios Alexiou (Author), Marios Papadakis (Author), Abdulrahman A. Alsayegh (Author), Najlaa Hamed Almohmadi (Author), Hebatallah M. Saad (Author), Gaber El‐Saber Batiha (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
by: Mohammed Alrouji, et al.
Published: (2024) -
Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator
by: Naif H. Ali, et al.
Published: (2023) -
The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis
by: Abdullah A. Alshehri, et al.
Published: (2024) -
Montelukast and Acute Coronary Syndrome: The Endowed Drug
by: Basil Mohammed Alomair, et al.
Published: (2022) -
Possible Role of Statins on the Inflammatory Biomarkers in Patients With Periodontal Disease: A Cross-Sectional Study
by: Sahar S Kadhim, et al.
Published: (2019)